A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma
Clinical trial NCT02919670 · COMPLETED
Trial details
- NCT number
- NCT02919670
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2019-05-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.